ORTEXORTEX News
Tracking HTGC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
HT
Corporate ActionHTGC

HTGC declares $0.07 supplemental dividend with short interest at a one-year extreme

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of Hercules Capital, Inc. (HTGC) share price and short interest (% of free float), six months to October 27, 2026

Hercules Capital, a business development company that lends to venture-backed technology and life-sciences firms, announced a supplemental cash distribution of $0.07 per share for the third quarter of 2026, payable on 17 November 2026. The payment is on top of any regular quarterly distribution.

For holders on the record date, the $0.07 is straightforward income. For short sellers, the mechanics run the other way: anyone borrowing HTGC shares is liable to pay a dividend-in-lieu, an amount equal to the dividend that the lender would otherwise have received, directly out of their position. With 6.1% of the free float currently sold short and roughly 10.4 million shares on loan, that obligation is not trivial at the aggregate level. The cost to borrow sits at just over 1%, and this week's increase in short interest ran 3.0 standard deviations above HTGC's typical weekly move over the past year, meaning the dividend announcement lands as new shorts are arriving in size.

Against its own history

This week's change in short interest is 3.0 standard deviations above the company's typical weekly move over the past year.

Stocks in this article

See the live data behind this article on ORTEX.

Open HTGC on ORTEX →

How this article was generated

Generated
28 Oct 2026, 14:25
Prompt version
v1.0
Data sources
Short interest

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.